首页> Nuclear Medicine Communications> Comparative serum proteomic analysis identified afamin as a downregulated protein in papillary thyroid carcinoma patients with non-131I-avid lung metastases

Comparative serum proteomic analysis identified afamin as a downregulated protein in papillary thyroid carcinoma patients with non-131I-avid lung metastases

导出原文传递

翻译打印收藏纠错

作者： Song,H.-J. ^[1] ; Xue,Y.-L. ; Qiu,Z.-L. ; Luo,Q.-Y.

作者单位： Department of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University ^[1]

关键词 biomarker lung metastases papillary thyroid carcinoma proteomics radioactive iodine treatment

发布时间 2013-12-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

Nuclear Medicine Communications

2013年34卷12期

1196-1203页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览3

点击下载本期目录封面

Nuclear Medicine Communications

2013年34卷12期

1196-1203页

检索历史清除

Comparative serum proteomic analysis identified afamin as a downregulated protein in papillary thyroid carcinoma patients with non-131I-avid lung metastases

Nuclear Medicine Communications

相似文献

Nuclear Medicine Communications

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparative serum proteomic analysis identified afamin as a downregulated protein in papillary thyroid carcinoma patients with non-131I-avid lung metastases

Nuclear Medicine Communications

相似文献

Nuclear Medicine Communications

相关期刊

检索历史清除